rs12512631 on the Group Specific Complement (Vitamin D-Binding Protein GC) Implicated in Melanoma Susceptibility

• Maria Peña-Chilet,

  Affiliation Medical Oncology and Haematology Unit, Health Research Institute INCLIVA, Valencia, Spain

  ⨯
• Maider Ibarrola-Villava,

  Affiliation Medical Oncology and Haematology Unit, Health Research Institute INCLIVA, Valencia, Spain

  ⨯
• Manuel Martin-González,

  Affiliation Dermatology Department, Ramon y Cajal Hospital, Madrid, Spain

  ⨯
• Marta Feito,

  Affiliation Dermatology Department, La Paz University Hospital, Madrid, Spain

  ⨯
• Cristina Gomez-Fernandez,

  Affiliation Dermatology Department, La Paz University Hospital, Madrid, Spain

  ⨯
• Dolores Planelles,

  Affiliation Laboratory of Histocompatibility-Molecular Biology, Centre for Blood Transfusion, Valencia, Spain

  ⨯
• Gregorio Carretero,

  Affiliation Dermatology Department, Doctor Negrín Hospital, Las Palmas de Gran Canaria, Spain

  ⨯
• Ana Lluch,

  Affiliation Medical Oncology and Haematology Unit, Health Research Institute INCLIVA, Valencia, Spain

  ⨯
• Eduardo Nagore,

  Affiliation Dermatology Department, Instituto Valenciano de Oncología, Valencia, Spain

  ⨯
• Gloria Ribas

  * E-mail: gribasdespuig@gmail.com

  Affiliation Medical Oncology and Haematology Unit, Health Research Institute INCLIVA, Valencia, Spain

  ⨯